Adam Morgan serves as Executive at HERON THERAPEUTICS, INC. /DE/, where they oversee executive responsibilities. Since joining the company, Adam Morgan has executed 9 insider transactions totaling $8.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 30, 2026 involved receiving (via award) 53,960 shares valued at $0.
Adam Morgan currently holds 123,737 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Morgan has been a net buyer of HRTX stock. They have purchased $8.4M and sold $0 worth of shares.
Adam Morgan's most recent insider trade was on Jan 30, 2026, when they sold 53,960 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.50 |
| Discretionary |
| Jan 19, 2024 | HRTX | $0 | Award | 13,948 | $N/A | Discretionary |
| Aug 15, 2023 | ALIM | $8.2M | Conversion | 4,845,392 | $1.70 | Discretionary |
| Aug 15, 2023 | ALIM | $7.1M | Conversion | 4,178,725 | $1.70 | Discretionary |
| Aug 15, 2023 | ALIM | $6.1M | Conversion | 2,924,762 | $2.10 | Discretionary |
| Jul 21, 2023 | HRTX | $3.4M | Purchase | 2,486,744 | $1.37 | Discretionary |
| May 17, 2023 | ALIM | $2.4M | Purchase | 1,401,901 | $1.70 | Discretionary |
| Feb 22, 2023 | HRTX | $0 | Award | 37,879 | $N/A | Discretionary |